Ruisheng Liu Selected Research

Degenerin Sodium Channels

1/2022

βENaC and ASIC2 associate in VSMCs to mediate pressure-induced constriction in the renal afferent arteriole.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruisheng Liu Research Topics

Disease

15	Hypertension (High Blood Pressure) 10/2021 - 01/2009
6	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 06/2013
5	Ischemia 01/2022 - 06/2013
3	Hemorrhage 01/2021 - 01/2017
3	Proteinuria 01/2020 - 01/2018
2	Reperfusion Injury 01/2022 - 01/2019
2	Obesity 10/2021 - 03/2012
2	Chronic Renal Insufficiency 10/2021 - 11/2019
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 10/2021 - 01/2021
2	Pre-Eclampsia (Preeclampsia) 01/2021 - 11/2013
2	Fibrosis (Cirrhosis) 01/2020 - 01/2019
2	Hyperglycemia 01/2019 - 01/2019
2	Necrosis 01/2019 - 01/2016
2	Solitary Kidney 01/2018 - 07/2015
2	Inflammation (Inflammations) 01/2018 - 01/2012
1	Delayed Graft Function 01/2022
1	Disease Progression 01/2022
1	Atherosclerosis 10/2021
1	Atrial Fibrillation 01/2021
1	Fabry Disease (Fabry's Disease) 01/2020
1	Thrombosis (Thrombus) 12/2019
1	Albuminuria 01/2019
1	Infarction (Infarctions) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2017
1	Hemorrhagic Shock 01/2017
1	Tetralogy of Fallot (Fallot Tetralogy) 01/2015
1	Right Ventricular Dysfunction 01/2015
1	Hyperaldosteronism (Conn Syndrome) 03/2012

Drug/Important Bio-Agent (IBA)

7	CreatinineIBA 01/2022 - 01/2016
6	Angiotensin IIIBA 10/2021 - 01/2012
4	Nitric Oxide Synthase (NO Synthase)IBA 10/2021 - 01/2016
3	SaltsIBA 01/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2015
2	tempolIBA 01/2018 - 01/2016
2	SodiumIBA 01/2016 - 01/2009
2	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 09/2014 - 04/2013
1	Degenerin Sodium ChannelsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 10/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2021
1	Uric Acid (Urate)IBA 01/2021
1	RivaroxabanIBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	AnticoagulantsIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2020
1	IsotopesIBA 01/2020
1	Levofloxacin (Levaquin)FDA Link 01/2020
1	Cytochrome P-450 CYP2C9IBA 12/2019
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 11/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	SolutionsIBA 01/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2018
1	Glycogen Synthase KinasesIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	AntioxidantsIBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Contrast MediaIBA 04/2014
1	Enalapril FDA LinkGeneric 11/2013
1	Endothelin-1 (Endothelin 1)IBA 11/2013
1	Testosterone (Sustanon)FDA Link 06/2013
1	AndrogensIBA 05/2013
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2012
1	AldosteroneIBA 03/2012
1	EnzymesIBA 01/2012
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2012
1	Heme Oxygenase-1IBA 01/2012
1	tin protoporphyrin IXIBA 01/2012
1	Superoxides (Superoxide)IBA 06/2010

Therapy/Procedure

4	Kidney Transplantation 01/2022 - 08/2017
3	Therapeutics 01/2022 - 12/2019
2	Transplantation 01/2022 - 01/2018
1	Warm Ischemia 01/2022
1	Intravenous Injections 01/2019
1	Ligation 01/2018
1	Operative Surgical Procedures 01/2017
1	Nephrectomy 07/2015